baber/WOPTO huggingface dataset:
Patent NZ-505485-A (NZ)
Title: Polyamines purified by ultrafiltration and lowering pH to less than 5.5
Inventor: TOMIZAWA AKIRA
IPC: A23L1/30
Filed: 2000-06-30
Abstract: A method of producing compositions containing polyamines easily and at low cost, in which milk or milk material is treated with an ultrafiltration (UF) membrane at a pH lower than 5.5 is described.  The polyamines produced by this method are isolated and then recovered from the resulting permeate.  The polyamines have a good flavour, contain high concentrations of spermidine and spermine and are highly utilizable as a food material.
Patent NZ-506168-A (NZ)
Title: System and process for remote payments and transactions in real time by mobile telephone
Inventor: DE CASSO BASTERRECHEA PABLO
IPC: G06Q20/00
Filed: 2000-08-04
Abstract: A system and a process for processing transactions between payers (13) and payees (14) that allows them to use any type of digital mobile phone without any modification. The payer uses his phone to contact a server (20) with a data store (22) containing information on each payerÆs details. These details at least include a valid telephone number, a safety criterion (e.g. a PIN) and an authorization criterion for authorizing a transaction for each payee. A second data store (21) contains additional information identifying the type of digital mobile telephone (16) belonging to each number. Thus the telecommunication service compatible with the type of mobile phone identified by the admissible telephone number can be selected and used.
Patent NZ-508731-A (NZ)
Title: Slide escape means from structures
Inventor: SIMMONS GARY FRANCIS
IPC: A63G21/10
Filed: 2000-12-08
Abstract: An exit means (1) for a structure including a slide (2), wherein the slide is formed about a central axis and around a central vent (5) within the interior of the structure. The slide preferably provides a fire escape, is of helical form, and can be accessed through controlled entry points (7) to provide a fast and safe means whereby occupants of a building exit same in an emergency.
Patent NZ-509049-A (NZ)
Title: Method and device for determining meat tenderness
Inventor: AIGNEL DENIS
IPC: G01N21/35
Filed: 1999-06-14
Abstract: The method disclosed is used for determining the quality of meat, in particular beef, on the transformation site, comprising the following steps: a) collecting, on the transformation site, data on parameters pertaining to the group consisting of the animal's race, age, and category, and biological and/or physico-chemical parameters of the animal's carcass pertaining to the group consisting of weight, conformation, fleshing, the carcass pH and colour, and the thickness of the hide; b) obtaining at least an optical spectrum of the meat at wavelengths pertaining to a spectral range from the visible to near-infrared; c) combining data obtained from steps a) and b), to determine the meat tenderness according to a predetermined law established with respect to a predetermined tenderness reference scale.
Patent NZ-510949-A (NZ)
Title: Fluticasone lotion having improved vasoconstrictor activity
Inventor: DOW GORDON J
IPC: A61K31/56
Filed: 1999-10-20
Abstract: A fluticasone lotion having improved vasoconstrictor and anti-inflammatory activity and higher than expected potency. The fluticasone lotion contains 0.005 -1.0 weight percent fluticasone, fatty alcohols, a skin conditioning agent, propolyne glycol and a mineral oil or white soft paraffin. The fluticasone lotion is unexpectedly efficacious while exhibiting an improved safety profile.
Patent NZ-513416-A (NZ)
Title: Pill dough formulation
Inventor: LEECH WAYNE FREDERICK
IPC: A21D2/00
Filed: 2002-07-09
Abstract: An edible dough for use in an oral delivery system is disclosed, wherein the dough comprises at least one flour; at least one soluble fibre including at least one gum; and at least one other pharmaceutically and or physiologically acceptable agent including at least glycerol; and wherein the dough is capable of being mounted around a medicament selected from the group including: a pill; pills; a capsule; capsules; a tablet; tablets; and combinations thereof; and further characterised in that the dough has extensibility characteristics that allow it to form a film with the medicament.
Patent NZ-514351-A (NZ)
Title: Compositions related to cDNA from overexpression of genes in breast cancer for the treatment and diagnosis of breast cancer and methods for their use
Inventor: YUQIU JIANG
IPC: A61K35/12
Filed: 2000-02-15
Abstract: Compositions and methods for the therapy and diagnosis of cancer, such as breast cancer, are disclosed. Compositions may comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as breast cancer. Diagnostic methods based on detecting a breast tumor protein, or mRNA encoding such a protein, in a sample are also provided. Particularly disclosed are compositions, nucleic acids and proteins relating to the cDNA sequence of the isoform B726P-20 as isolated from a breast tumor cDNA subtraction library (subtracted with normal breast cDNA).
Patent NZ-514587-A (NZ)
Title: Hinged bucket for collecting, cleaning and calibrating electrolysis pots used for aluminium production
Inventor: PIRON GERARD
IPC: B66C3/16
Filed: 2001-10-02
Abstract: A unit for collecting, cleaning and calibrating electrolysis pots as the anodes of the installation for the production of aluminum by igneous electrolysis are replaced comprises two buckets (16,17) hinge mounted at the level of the lower edge of a chassis (10) movable in vertical displacement and a first (10) and second chassis (11). The lower edge (31) of each of the buckets (16,17) is liable to be bestowed with a circular movement by means of a closing and opening connecting rod assembly (14,14'). The first chassis (10) (the shovel bearing chassis) is joined to a vertical guide mast (5) and the second chassis (11) (the buckets supporting chassis) is mechanically linked to the shovel bearing chassis and liable to displacement relative to the latter.  The bucket supporting chassis integrates the connecting rod assembly for closing and opening the buckets with the buckets being hinge mounted at the lower end of this chassis.
Patent NZ-515216-A (NZ)
Title: UV-absorbers with an affinity for textile fibres
Inventor: DETERING JURGEN
IPC: D06L4/60
Filed: 2000-04-17
Abstract: A compound of formula (II) is useful as a UV absorber that possesses affinity for textile fibers in cellulosic textile materials. In formula (II): X is -CR1=CR2; R1 and R2 are independently H, alkyl, alkoxy, alkoxycarbonyl, acyloxy, carboxyl, cyano, nitro, F, Cl, Br, sulphonyl, alkylsulphonyl, or optionally substituted phenyl or R1 can also be -NQ-CO- which is bonded with its carbonyl carbon atom to the ortho position of the adjacent phenyl ring to form a benzopyrrolidine system; Q is H or alkyl; Z is alkyl, alkoxy, alkoxycarbonyl, acyloxy, carboxyl, cyano, Cl, F, Br, nitro, sulphonyl, alkylsulphonyl, amino, monoalkylamino, dialkylamino, optionally alkyl substituted carboxamido, or optionally saturated, 5 or 6 membered heterocyclic radical that can be optionally benzofused or any two adjacent Z radicals can form an optionally saturated 5 or 56 membered ring and if p is 0 an ortho disposed carboxyl group may be combined with the carbonyl group present and a nitrogen atom attached directly to this carbonyl group to form a cyclic imide; n is 1 to 3; p is 0 to 5; Y is a aliphatic, cycloaliphatic or mixed aliphatic-aromatic radical which has at least m' primary and/or secondary amino groups for forming amide bonds with the structural unit of formula (I) and the group Y can be also quaternized at the tertiary and/or free primary and/or secondary nitrogen atoms present or still present and m' is 1 to 200 where m if the structural units (I) accounts form 10 to 1000% if the m; provided that however at least one structural unit (I) is present in the compound of formula (II).
Patent NZ-515581-A (NZ)
Title: Fibrin sealants providing less inflammatory response and methods using same
Inventor: FAIRBROTHER JOHN E
IPC: A61L31/04
Filed: 2000-06-01
Abstract: A method of preventing post surgical adhesions at a surgical site using a fibrin sealant wherein said fibrin sealant is prepared so as to induce little or no inflammatory response at the surgical site. Also described is the fibrin sealant and its use in downregulating nitric acid formation.
Patent NZ-518261-A (NZ)
Title: Fixation device
Inventor: FRIGG ROBERT
IPC: A61B17/74
Filed: 1999-12-03
Abstract: The intramedullary nail (1) serves for fixating femoral fractures. It has a distal end (2) adapted to be inserted into the medullary canal, a proximal end (3), and a longitudinal axis (4). A first bore (5), situated closer to the proximal end (3) and obliquely intersecting the longitudinal axis (4), serves for receiving a femur head screw (10), the central axis (6) of the first bore (5) forming an angle of between 110 and 150 degrees relative to the longitudinal axis (4). A second bore (7), situated between the first bore (5) and the proximal end (3) and obliquely intersecting the longitudinal axis (4), serves for receiving a femur head pin (20). The second bore (7) is at least in part shaped in the form of an elongate hole with a width B and a length L > B, the length L of the elongate hole extending in the direction of the longitudinal axis (4).
Patent NZ-518351-A (NZ)
Title: Laser apparatus
Inventor: RONVIG JORN
IPC: A61B18/20
Filed: 2000-09-15
Abstract: A laser apparatus (1) is provided comprising a laser light emitting optical system for emitting laser light to a surface, a power stabilising system for stabilising the laser light power within a predetermined power interval, and a deflection system (8) for deflecting light reflected from the surface away from the power stabilising system. Thereby, the power stabilizing system will not erroneously regulate the power due to reflections from the surface to be treated. Furthermore, a method of treatment is disclosed, excluding a human being, for a laser light treatable disease using the laser apparatus (1) on the skin or the mucosa of the animal and allowing laser light to be emitted from the laser light emitting optical system to the skin or mucosa.
Patent NZ-518485-A (NZ)
Title: Thermoplastics tray with spikes inward of raised perimeter to retain meat or fish
Inventor: PATTERSON MILES ROYLANCE
IPC: B65D77/00
Filed: 2002-04-18
Abstract: Upstanding spikes are provided inwards of a raised perimeter for retaining meat or fish.
Patent NZ-520143-A (NZ)
Title: Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
Inventor: WAGLE DILIP
IPC: A61P19/02
Filed: 2001-01-19
Abstract: Compounds of formula (I) or (IA) that are suitable for treating certain fibrotic diseases are disclosed, wherein the variables are as defined in the specification. Also described are methods of treatment with such compounds.
Patent NZ-522538-A (NZ)
Title: Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 their use and preparation
Inventor: BARF TJEERD
IPC: A61K31/437
Filed: 2001-05-22
Abstract: Compounds of formula (I) their pharmaceutical compositions, the processes for their preparation, as well as to their use in medicine and for the preparation of a medicament which acts on the human 11- beta -hydroxysteroid dehydrogenase type 1 enzyme are disclosed, wherein: T is 1) thienyl, which is optionally substituted with at least one halogen, or 2) phenyl substituted with a) at least one C2-6-alkyl; or b) at least one C1-6-alkyl and at least one halogen; or c) at least three halogens; E is a bond, -CH2- or -CO-; L is a bond, -CH2, -CHR4- or -NR3-; R3 is H, C1-6-alkyl, C1-6-acyl or -COR4; R4 is morpholinyl or C1-6-amido; R6 and R7 are independently H or C1-6-alkyl; and R8 and R9 are independently H or C1-6-alkyl.
Patent NZ-528302-A (NZ)
Title: Pharmaceutical salts of pharmaceutically active compounds and sugar substitutes
Inventor: BARTHOLOMAUS JOHANNES
IPC: A61K47/32
Filed: 2002-02-28
Abstract: Disclosed are pharmaceutical salts of a pharmaceutically active compound and at least one sugar substituted, wherein the salt-forming active compound is a 1-phenyl-3-dimethylaminopropane compound of formula I or a 6-dimethylaminomethyl-1-phenylcyclohexane compound of formula II. Compounds of the type disclosed are useful in the treatment of pain and urinary incontinence.
Patent NZ-534397-A (NZ)
Title: Lactobacillus rhamnosus carboxylesterase
Inventor: GLENN MATTHEW
IPC: A61P31/04
Filed: 2001-11-28
Abstract: Polynucleotides isolated from Lactobacillus rhamnosus, as well as probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, microorganisms and multicellular organisms incorporating the polynucleotides, polypeptides expressed by the polynucleotides, and methods for using the polynucleotides and polypeptides are disclosed. Particularly disclosed is a carboxylesterase that converts a carboxylic ester to an alcohol and a carboxylic acid anion. Esters and alcohols can be potent flavor and aroma compounds, and the protein of the disclosure is used to identify or impact on metabolism or flavor or aroma compound production.
Patent NZ-534692-A (NZ)
Title: Improved muting for frequency modulated receivers in the absence of a message or in unacceptable noise conditions
Inventor: SCOTT IAN RUSSELL
IPC: H03G3/34
Filed: 2004-08-13
Abstract: Muting a frequency modulated receiver in the absence of a message or in unacceptable noise conditions by receiving a signal, converting the signal into a stream of digital samples, converting the digital samples into in-phase and quadrature components, determining the difference in power between adjacent samples, averaging the differences, and operating the receiver mute on the basis of the averaged power difference.
Patent NZ-536018-A (NZ)
Title: Incremental material urging system
Inventor: BYRNE LAURENCE MICHAEL
IPC: B65G25/08
Filed: 2003-03-21
Abstract: An incremental material urging system comprising (a) a container structure (1) having a rear end and a forward end, (b) material urging structure (12) (c) material urging structure activating means (46) wherein said material urging structure is incrementally advanced from a retracted position at the rear end of said container structure, to a fully advanced position at the forward end of said container structure, where said forward end is a discharge end.
Patent NZ-536663-A (NZ)
Title: Process for the preparation of pharmaceutically acceptable salts of selective piperazinyl 5-HT2c receptor ligands
Inventor: CERNERUD MAGNUS
IPC: A61P43/00
Filed: 2003-06-18
Abstract: Disclosed is a process for the preparation of compounds of the general formula (I) which bind to the 5-HT2c receptor (agonists and antagonists) and therefore may be used for the treatment or prophylaxis of serotonin-related disorders such as obesity and type II diabetes. The process comprises the steps of (1) O-alkylating a 3-pyridinol derivative (2) reacting the resultant 3-pyridinol derivative with (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpyrazine and (3) converting the compound by treatment with a pharmaceutically acceptable acid of the formula HA.
Patent NZ-538425-A (NZ)
Title: Method for identifying thawed and refrozen products by forming indentation that is irreversably altered when product thawed
Inventor: LIBERMAN BARNET
IPC: A23G9/22
Filed: 2003-08-28
Abstract: A method of freezing a product comprises the step of forming an indentation on the frozen food product. Such identification is capable of being irreversibly altered after the frozen food product is thawed so that it is an indication that the frozen food product has been thawed during storage.
Patent NZ-540622-A (NZ)
Title: An electrostatic precipitator
Inventor: CLARK JAMES MCDONALD
IPC: B03C3/06
Filed: 2003-11-11
Abstract: An electrostatic precipitator is provided. The electrostatic precipitator comprises a conduit for the passage of particles in an air flow. The electrostatic precipitator also comprises means for generating an electrostatic field substantially orthogonal to the air flow, and an ion supply capable of charging the particles. The generating means comprise a point electrode and a two dimensional surface electrode. The two dimensional surface electrode comprises an ion source. The point electrode comprises a counter electrode, which is earthed. The conduit comprises a hollow cylinder, and the two dimensional surface electrode is adapted to cover at least a part of the inner surface of the hollow cylinder.
Patent NZ-542588-A (NZ)
Title: Animal shelter with removable cover and roof ventilation gap
Inventor: MCCREDIE ROBERT
Filed: 2005-09-22
Abstract: A shelter, especially an animal or farm shelter, includes two sets of overlapping roof frames, one upper set 7 being vertically offset and overlapping the bottom set 8, with the sets of frames being adjacent to but spaced apart from each other to provide a shelter of a required size. Covers 21 and 24 are stretched over the respective frame sets to cover the shelter and provide a gap between the upper and lower covers for ventilation of the shelter. The covers are attached to the frames by attachment lanyards 23, 26 and hooks 22, 25 hooked over the ends of the frames. When required the covers can be removed to allow the area within the shelter to be exposed to the elements.
Patent NZ-543349-A (NZ)
Title: Olefin epoxidation catalyst and process for producing oxirane compound with the catalyst
Inventor: WATANABE HISAYUKI
IPC: B01J23/30
Filed: 2004-04-21
Abstract: Disclosed is an olefin oxidation catalyst which is prepared from: a polymer compound selected from polyimides, acrylamides, methacrylamides, polyamides or polyurethanes or an organic compound of formula (1), wherein the substituents are as defined in the specification; a tungstic acid compound; a phosphoric acid; hydrogen peroxide; and a quaternary ammonium salt of formula (2) or (3), wherein the substituents are as defined in the specification.
Patent NZ-544784-A (NZ)
Title: Treatment and prevention of cardiovascular events using a beta-adrenergic receptor antagonist, a diuretic, an inhibitor of HMG CoA reductase, an inhibitor of the rennin-angiotensin system and asprin; wherein acidic and basic components are separated.
Inventor: SASMAL BADAL KUMAR
IPC: A61K31/616
Filed: 2004-07-28
Abstract: Discloses a pharmaceutical dosage form comprising therapeutic amounts of: a Beta-adrenergic receptor antagonist and/or a diuretic; an inhibitor of HMG CoA reductase; an inhibitor of the rennin-angiotensin system; and aspirin; wherein acidic components are separated from basic components. The pharmaceutical dosage form reduces risk of cardiovascular event with minimal or no physical and chemical incompatibility, and gives reduced side effects normally associated with use of such active agents.
Patent NZ-549386-A (NZ)
Title: (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
Inventor: ADAM-WORRALL JULIA
IPC: A61K31/5383
Filed: 2005-02-28
Abstract: Disclosed is an (indol-3-yl)-heterocycle derivative of formula I, wherein A is a 5-membered aromatic heterocyclic ring where X1, X2, and X3 are each N, O, S, or CR, R is H or C1-4alkyl, R1 is a 5-8 membered saturated carbocylic ring, optionally containing a heteroatom selected from O or S, R2 and R7 may be joined to form a 6-membered ring, and wherein the other substituents are as described in the specification. Also disclosed is the use of the compound for treating pain.
Patent NZ-549914-A (NZ)
Title: A striker plate, a door jamb assembly and a method of securing a striker plate to a door surround structure
Inventor: FARRELL SHELLEY ELLEN
Filed: 2006-09-18
Abstract: A striker plate 11 having projections 19 such that when the striker plate is inserted into a door jamb the projections engage with the door jamb Fc and provide sufficient biasing to retain the striker plate in the required lateral and vertical location while it is being secured. The striker plate has one or more openings 14 to receive one or more lock bolts of a lock.
Patent NZ-566467-A (NZ)
Title: Methods and apparatus for vascular protection in spinal surgery
Inventor: MORGAN MICKEY DEAN
IPC: A61B17/88
Filed: 2006-08-07
Abstract: Methods and apparatus are provided for: coupling an elongate guide substantially at a first end to at least one vertebral body of a spinal column of a patient; and extending a second end of the guide to a structure of the patient spaced in an anterior direction away from the at least one vertebral body towards an entry incision.
Patent NZ-569449-A (NZ)
Title: Resilient mounting for an inline fan for ducting systems
Inventor: STERLING MICHAEL WILLIAM
Filed: 2008-06-27
Abstract: This discloses a resilient mounting 2 for an object, that includes: a base14, an engagement member 70 which engages the object to be mounted, first and second support elements 16, 18 which extend from the base 14 to the engagement member 70 the first and second support elements 16, 18 being resiliently deformable, a band 6 which can extend about the object, the band 6 having free ends and coupling means 10, 12 for coupling free ends of the band to the mounting at 60, 60. When the mounting is used, the object is clamped between the engagement member 70 and the band 8.
Patent NZ-576262-A (NZ)
Title: Method of isolating biomacromolecules using low ph and divalent cations
Inventor: ROMERO JONATHAN
IPC: B01D37/04
Filed: 2007-11-01
Abstract: Disclosed is a method of isolating, purifying, or clarifying an antibody in a composition containing an impurity, wherein said impurity comprises a non-soluble protein, lipid, nucleic acid, ribonucleic acid or any combination thereof, the method comprising: (a) lowering the pH of said composition to a pH range of 3.0 to 6.5; (b) adding a divalent cation selected from the group consisting of Ca2+, Mg2+, Cu2+, Co2+, Mn2+, Ni2+, Ba2+, Sr2+, Ba2+, Ra2+, Zn2+,Cd2+,Ag2+,Pd2+, Rh2+ and combinations thereof to said composition, wherein the adding results in a divalent cation concentration of 0.1 mM to 500 mM; and (c) separating said antibody from said impurity, wherein the separating of (c) is performed by subjecting said composition to centrifugation, said centrifugation forming a supernatant and a precipitate wherein said antibody is substantially in said supernatant, or wherein the separating of (c) is performed by filtering said composition, said filtering forming a permeate stream and a retentate stream wherein said antibody is substantially in said permeate stream, and wherein steps (a) and (b) are carried out sequentially in any order before step (c).
Patent NZ-576445-A (NZ)
Title: Hybrid immunoglobulins with moving parts
Inventor: CAPON DANIEL J
IPC: C07K1/00
Filed: 2007-10-31
Abstract: Disclosed is a method of producing a protein which comprises: (a) producing a protein which comprises a first polypeptide contiguous with an intein, which intein is contiguous with a second polypeptide comprising a binding domain, wherein said first polypeptide is a fusion polypeptide comprising a heterologous N terminal signal sequence which can direct secretion of the protein, wherein protein production comprises transfecting an eukaryotic cell with a nucleic acid, which nucleic acid comprises (i) a first portion which encodes the polypeptide, contiguous with (ii) a second portion which encodes the intein, contiguous with (iii) a third portion which encodes a binding domain, under conditions such that the eukaryotic cell expresses and secretes the protein; (b) generating a thioester intermediate following an intein autocleavage reaction and adding a cysteine, homocysteine, selenocysteine, homoselenocysteine or a functional analogue thereof to the C-terminus by native chemical ligation, wherein, when the eukaryotic cell is a human cell, the protein is produced ex vivo.